SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-060511
Filing Date
2018-11-16
Accepted
2018-11-16 16:11:32
Documents
4
Period of Report
2018-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv507236_8k.htm 8-K 24481
2 EXHIBIT 5.1 tv507236_ex5-1.htm EX-5.1 9428
3 EXHIBIT 10.1 tv507236_ex10-1.htm EX-10.1 203975
4 GRAPHIC image_001.jpg GRAPHIC 1858
  Complete submission text file 0001144204-18-060511.txt   241995
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 181189958
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services